Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750

被引:123
作者
Barchiesi, F
Calabrese, D
Sanglard, D
Di Francesco, LF
Caselli, F
Giannini, D
Giacometti, A
Gavaudan, S
Scalise, G
机构
[1] Univ Ancona, Azienda Osped, Ist Malattie Infet & Med Pubbl, I-60121 Ancona, Italy
[2] CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland
[3] Ist Zooprofilatt Sperimentale Umbria Marche, Perugia, Italy
关键词
D O I
10.1128/AAC.44.6.1578-1584.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida tropicalis is less commonly isolated from clinical specimens than Candida albicans. Unlike C. albicans, which can be occasionally found as a commensal, C. tropicalis is almost always associated with the development of fungal infections. In addition, C. tropicalis has been reported to be resistant to fluconazole (FLC). To analyze the development of FLC resistance in C. tropicalis, an FLC-susceptible strain (ATCC 750) (MIC = 1.0 mu g/ml) was cultured in liquid medium containing increasing FLC concentrations from 8.0 to 128 mu g/ml. The strain developed variable degrees of FLC resistance which paralleled the concentrations of FLC used in the medium. The highest MICs of FLC were 16, 256, and 512 mu g/ml for strains grown in medium with 8.0, 32, and 128 mu g of FLC per mi, respectively. Development of resistance was rapid and could be observed already after a single subculture in azole-containing medium. The resistant strains were cross-resistant to itraconazole (MIC > 1.0 mu g/ml) and terbinafine (MIC > 512 mu g/ml) but not to amphotericin B. Isolates grown in FLC at concentrations of 8.0 and 32 mu g/ml reverted to low MICs (1.0 mu g/ml) after 12 and II passages in FI,C-free medium, respectively. The MIC for one isolate grown in FLC (128 mu g/ml) (128 R) reverted to 16 mu g/ml but remained stable over 60 passages in FLC-fi-ee medium. Azole-resistant isolates revealed upregulation of two different multidrug efflux transporter genes: the major facilitators gene MDR1 and the ATP-binding cassette transporter CDR1. The development of FLC resistance in vitro correlated well with the results obtained in an experimental model of disseminated candidiasis. While FLC given at 10 mg/kg of body weight/day was effective in reducing the fungal burden of mice infected with the parent strain, the same dosing regimen was ineffective in mice infected with strain 128 R. Finally, the acquisition of in vitro PLC resistance in strain 128 R was related to a loss of virulence. The results of our study elucidate important characteristics and potential mechanisms of FLC resistance in C. tropicalis.
引用
收藏
页码:1578 / 1584
页数:7
相关论文
共 39 条
[1]   Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance [J].
Albertson, GD ;
Niimi, M ;
Cannon, RD ;
Jenkinson, HF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2835-2841
[2]   IN-VITRO ACTIVITY OF ITRACONAZOLE AGAINST FLUCONAZOLE-SUSCEPTIBLE AND FLUCONAZOLE-RESISTANT CANDIDA-ALBICANS ISOLATES FROM ORAL CAVITIES OF PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
BARCHIESI, F ;
COLOMBO, AL ;
MCGOUGH, DA ;
FOTHERGILL, AW ;
RINALDI, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1530-1533
[3]   Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model [J].
Barchiesi, F ;
Najvar, LK ;
Luther, MF ;
Scalise, G ;
Rinaldi, MG ;
Graybill, JR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1317-1320
[4]   Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis [J].
Barchiesi, F ;
Arzeni, D ;
Del Prete, MS ;
Sinicco, A ;
Di Francesco, LF ;
Pasticci, MB ;
Lamura, L ;
Nuzzo, MM ;
Burzacchini, F ;
Coppola, S ;
Chiodo, F ;
Scalise, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (05) :541-548
[5]   In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp. [J].
Barchiesi, F ;
Tortorano, AM ;
Di Francesco, LF ;
Cogliati, M ;
Scalise, G ;
Viviani, MA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) :295-299
[6]   REDUCED VIRULENCE OF CANDIDA-ALBICANS MUTANTS AFFECTED IN MULTIDRUG-RESISTANCE [J].
BECKER, JM ;
HENRY, LK ;
JIANG, WD ;
KOLTIN, Y .
INFECTION AND IMMUNITY, 1995, 63 (11) :4515-4518
[7]   Induction of resistance to azole drugs in Trypanosoma cruzi [J].
Buckner, FS ;
Wilson, AJ ;
White, TC ;
Van Voorhis, WC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) :3245-3250
[8]   Reversible fluconazole resistance in Candida albicans: A potential in vitro model [J].
Calvet, HM ;
Yeaman, MR ;
Filler, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :535-539
[9]   ISOLATION OF THE CANDIDA-TROPICALIS GENE FOR P450 LANOSTEROL DEMETHYLASE AND ITS EXPRESSION IN SACCHAROMYCES-CEREVISIAE [J].
CHEN, C ;
TURI, TG ;
SANGLARD, D ;
LOPER, JC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 146 (03) :1311-1317
[10]  
COMO JA, 1994, NEW ENGL J MED, V330, P263, DOI 10.1056/NEJM199401273300407